WHO ICTRP trial
Efficacy of propiverine in patients with neurogenic detrusor overactivity
EUCTR2012-003159-12-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2012-003159-12-DE |
|---|---|
| Public title | Efficacy of propiverine in patients with neurogenic detrusor overactivity |
| Scientific title | Efficacy of propiverine hydrochloride extended release (ER) 45 mg in patients with neurogenic detrusor overactivity – an active-controlled single center crossover trial |
| Primary sponsor | APOGEPHA Arzneimittel GmbH |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Germany |
| Conditions | neurogenic detrusor overactivity MedDRA version: 16.0 Level: LLT Classification code 10012547 Term: Detrusor hyperreflexia System Organ Class: 100000004857 ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10] |
| Interventions | Trade Name: Mictonorm Uno Pharmaceutical Form: Modified-release capsule, hard Other descriptive name: PROPIVERINE HYDROCHLORIDE Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 45- Pharmaceutical form of… |
| Registration date | Aug 22, 2012 |
| Secondary IDs | 8405011 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: